Published on 2 May 2024 on GuruFocus.com via Yahoo Finance

Avanos Medical Inc (AVNS) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses Revenue Estimates

Revenue: Reported $166.1 million, up 4.3% year-over-year, surpassing estimates of $162.90 million.Net Income: From continuing operations was $0.5 million, a significant improvement from a net loss of $7.8 million in the prior year, but below the estimated $0.90 million.Earnings Per Share (EPS): Adjusted diluted EPS from continuing operations was $0.22, exceeding the estimated $0.21.Gross Margin: Adjusted gross margin slightly increased to 59.8% from 59.6% year-over-year.Operating Profit: Turned to a profit of $4.0 million from an operating loss of $6.1 million in the prior year period.Adjusted EBITDA: Increased to $21.6 million from $16.1 million in the comparable period last year.Free Cash Flow: Reported an outflow of $12.1 million, worsening from an outflow of $10.8 million in the previous year.

Warning! GuruFocus has detected 2 Warning Signs with AVNS.